Literature DB >> 7954919

Structural features and anti-complementary activity of rehmannan SA, a polysaccharide from the root of Rehmannia glutinosa.

M Tomoda1, H Miyamoto, N Shimizu.   

Abstract

The structural features of rehmannan SA, a polysaccharide with remarkable reticuloendothelial system-potentiating activity obtained from the root of Rehmannia glutinosa, were investigated by methylation analysis and periodate oxidation. Rehmannan SA is mainly made up of arabino-3,6-galactan type structural units. Both rehmannan SA and rehmannan SB showed pronounced anti-complementary activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7954919     DOI: 10.1248/cpb.42.1666

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  5 in total

1.  Hot water-extracted Lycium barbarum and Rehmannia glutinosa inhibit proliferation and induce apoptosis of hepatocellular carcinoma cells.

Authors:  Jane C-J Chao; Shih-Wen Chiang; Ching-Chiung Wang; Ya-Hui Tsai; Ming-Shun Wu
Journal:  World J Gastroenterol       Date:  2006-07-28       Impact factor: 5.742

2.  Rehmannia glutinosa polysaccharide induces toll-like receptor 4 dependent spleen dendritic cell maturation and anti-cancer immunity.

Authors:  Li Xu; Minseok Kwak; Wei Zhang; Ling Zeng; Peter Chang-Whan Lee; Jun-O Jin
Journal:  Oncoimmunology       Date:  2017-05-12       Impact factor: 8.110

Review 3.  Anti-Inflammatory and Antioxidant Chinese Herbal Medicines: Links between Traditional Characters and the Skin Lipoperoxidation "Western" Model.

Authors:  Jose M Prieto; Guillermo R Schinella
Journal:  Antioxidants (Basel)       Date:  2022-03-23

4.  Acteoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-κB pathway and attenuating ROS production.

Authors:  Seung-Youp Lee; Keun-Soo Lee; Sea Hyun Yi; Sung-Ho Kook; Jeong-Chae Lee
Journal:  PLoS One       Date:  2013-12-04       Impact factor: 3.240

Review 5.  Drug delivery for bioactive polysaccharides to improve their drug-like properties and curative efficacy.

Authors:  Zhe Li; LiNa Wang; Xiao Lin; Lan Shen; Yi Feng
Journal:  Drug Deliv       Date:  2017       Impact factor: 6.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.